Health Canada Advisory: Evusheld

1 November 2022

The following was published on Health Canada’s Recalls and Safety Alerts web page:

The Canadian Product Monograph for EVUSHELD has been updated with new information about the risk of prophylaxis or treatment failure due to antiviral resistance, including neutralization data on SARS-CoV-2 Omicron subvariants. Read more…

Receive notifications for new and updated recalls and alerts by category.

↑ Back to top ↑